Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= EDNRB ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: EDNRB * **<color #00a2e8>Official Name</color>**: endothelin receptor type B * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1910|1910]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P24530|P24530]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=EDNRB&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EDNRB|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/131244|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: The protein encoded by this gene is a G protein-coupled receptor which activates a phosphatidylinositol-calcium second messenger system. Its ligand, endothelin, consists of a family of three potent vasoactive peptides: ET1, ET2, and ET3. Studies suggest that the multigenic disorder, Hirschsprung disease type 2, is due to mutations in the endothelin receptor type B gene. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]. * **<color #00a2e8>UniProt Summary</color>**: N/A <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |7TM GPCR Srsx| |7tm 1| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |enteric smooth muscle cell differentiation| |response to endothelin| |endothelin receptor activity| |posterior midgut development| |endothelin receptor signaling pathway| |negative regulation of neuron maturation| |vein smooth muscle contraction| |positive regulation of penile erection| |type 1 angiotensin receptor binding| |regulation of penile erection| |negative regulation of cell maturation| |regulation of fever generation| |epithelial fluid transport| |regulation of neuron maturation| |enteric nervous system development| |regulation of heat generation| |midgut development| |macrophage chemotaxis| |positive regulation of renal sodium excretion| |positive regulation of urine volume| |vascular smooth muscle contraction| |transepithelial transport| |phasic smooth muscle contraction| |negative regulation of adenylate cyclase activity| |macrophage migration| |negative regulation of cyclase activity| |melanocyte differentiation| |regulation of renal sodium excretion| |regulation of urine volume| |negative regulation of lyase activity| |regulation of cell maturation| |regulation of excretion| |cGMP-mediated signaling| |fluid transport| |regulation of adenylate cyclase activity| |response to pain| |vasodilation| |vasoconstriction| |pigment cell differentiation| |smooth muscle cell differentiation| |regulation of renal system process| |negative regulation of blood vessel diameter| |regulation of sensory perception of pain| |peptide hormone binding| |regulation of sensory perception| |developmental pigmentation| |regulation of cyclase activity| |regulation of acute inflammatory response| |regulation of lyase activity| |autonomic nervous system development| |smooth muscle contraction| |neural crest cell migration| |positive regulation of blood vessel diameter| |multicellular organismal response to stress| |peripheral nervous system development| |sensory perception of pain| |positive regulation of reproductive process| |neural crest cell development| |mesenchymal cell development| |stem cell development| |neural crest cell differentiation| |pigmentation| |phospholipase C-activating G protein-coupled receptor signaling pathway| |regulation of pH| |renal system process| |myeloid leukocyte migration| |digestive tract development| |regulation of nervous system process| |regulation of tube diameter| |regulation of blood vessel diameter| |monovalent inorganic cation homeostasis| |regulation of tube size| |digestive system development| |leukocyte chemotaxis| |calcium-mediated signaling| |mesenchymal cell differentiation| |stem cell differentiation| |regulation of reproductive process| |vascular process in circulatory system| |cyclic-nucleotide-mediated signaling| |ameboidal-type cell migration| |regulation of blood pressure| |cellular response to lipopolysaccharide| |cellular response to molecule of bacterial origin| |cell chemotaxis| |cellular response to biotic stimulus| |mesenchyme development| |negative regulation of neuron differentiation| |membrane raft| |nuclear membrane| |muscle cell differentiation| |muscle contraction| |aging| |positive regulation of cytosolic calcium ion concentration| |negative regulation of neurogenesis| |muscle system process| |negative regulation of nervous system development| |response to lipopolysaccharide| |response to molecule of bacterial origin| |regulation of cytosolic calcium ion concentration| |regulation of epithelial cell proliferation| |negative regulation of cell development| |second-messenger-mediated signaling| |regulation of inflammatory response| |leukocyte migration| |blood circulation| |response to peptide hormone| |circulatory system process| |positive regulation of secretion| |cellular calcium ion homeostasis| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |response to peptide| |muscle structure development| |divalent inorganic cation homeostasis| |regulation of body fluid levels| |positive regulation of multi-organism process| |regulation of anatomical structure size| |cellular response to lipid| |chemotaxis| |taxis| |cellular metal ion homeostasis| |regulation of system process| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |regulation of neuron differentiation| |response to bacterium| |cation homeostasis| |negative regulation of cell differentiation| |inorganic ion homeostasis| |cellular chemical homeostasis| |regulation of defense response| |regulation of multi-organism process| |ion homeostasis| |negative regulation of catalytic activity| |regulation of secretion| |regulation of neurogenesis| |tube development| |response to lipid| |negative regulation of transcription by RNA polymerase II| |negative regulation of apoptotic process| |cellular homeostasis| |negative regulation of programmed cell death| |response to hormone| |positive regulation of cell population proliferation| |response to organic cyclic compound| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |cell migration| |sensory perception| |positive regulation of transport| |negative regulation of cell death| |response to organonitrogen compound| |positive regulation of protein phosphorylation| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |localization of cell| |cell motility| |response to nitrogen compound| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |chemical homeostasis| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |response to other organism| |response to external biotic stimulus| |locomotion| |G protein-coupled receptor signaling pathway| |response to biotic stimulus| |negative regulation of RNA metabolic process| |nervous system process| |negative regulation of cellular macromolecule biosynthetic process| |integral component of plasma membrane| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |generation of neurons| |regulation of apoptotic process| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |neurogenesis| |homeostatic process| |cell development| |regulation of cell death| |intracellular signal transduction| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of multicellular organismal process| |tissue development| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |regulation of protein modification process| |regulation of transport| |system process| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp17|DABN 20μM R00 exp17]]|-2.33| |[[:results:exp139|Nicotinamide Riboside 100μM R03 exp139]]|-1.71| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.72| |[[:results:exp471|Cholesterol 0.003 to 0.006 to 0.1μM on day2 then day6 R08 exp471]]|1.74| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 11798 * **<color #00a2e8>Expression level (log2 read counts)</color>**: -4.01 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='EDNRB Expression in NALM6 Cells: -4.01'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2025/12/10 20:19by 127.0.0.1